Johns Hopkins/NCI Molecular Target and Drug Discovery Fellowship
The Johns Hopkins University and the Center for Cancer Research (CCR) at the National Cancer Institute (NCI) have partnered to create a new concentration in the Master of Science in Biotechnology program, called Molecular Targets and Drug Discovery Technologies. This innovative program focuses on bioassay development, chemical libraries, molecular targets and cancer, and high-throughput screening laboratory automation.
A special feature of the concentration is the NCI-CCR Fellowship Program. This competitive program will recruit immediate post-baccalaureates to work in NCI-CCR laboratories on projects related to the Molecular Targets Initiative.
While studying for the Master of Science in Biotechnology, the fellows will receive paid tuition for up to two years and an annual stipend. Ten Courses will be required for graduation (4 core courses, 6 electives). Practical lab courses are included as part of the curriculum.
Core Science Courses
- Molecular Biology
- Advanced Cellular Biology I
- Advanced Cellular Biology II
(4 courses required)
Core Molecular Targets and Drug Discovery Technologies Courses
- Molecular Targets and Cancer
- Bioassay Development
- Chemical Libraries and Diversity
- High-Throughput Screening and Automation Laboratory
(4 courses required)
- Molecular Basis of Pharmacology
- Introduction to Bioinformatics
- Protein Bioinformatics
- Cell Culture Techniques
- Microarray and Analysis
- Microfluids and Biosensors
(2 courses selected)
Project Proposals are now closed.
To apply or learn more about this program, visit the Johns Hopkins University Center for Biotechnology Education.
NOTE: In order to be approved for logistical and physical access to NIH facilities and systems, candidates must be able to pass a Federal background check using Standard Form-85 (read-SF-85). Section 14 of the Form asks, "in the last year, have you used, possessed, supplied, or manufactured illegal drugs?" The questions pertain to the illegal use of drugs or controlled substances in accordance with Federal laws, even though permissible under state laws. Federal laws supersede all state laws.
Jonathan S. Wiest, Ph.D.
Center for Cancer Training
National Cancer Institute
9609 Medical Center Drive
Bethesda, MD 20892